skip to content
  1. Home
  2. >
  3. Investment Q&A
You can view 3 more answers this month. Sign up for a free trial for unlimited access.

Investment Q&A

Not investment advice or solicitation to buy/sell securities. Do your own due diligence and/or consult an advisor.

Q: I own ILMN, VEEV, GH but not LNTH. Would you recommend a switch to LNTH for more growth? I can use ILMN and VEEV for a tax loss - should these be repurchased or just buy LNTH (or another stock?)for more growth?

Thanks for your service !
Read Answer Asked by Ozzie on October 17, 2022
Q: Hello,

I've had these three healthcare companies on my watchlist for some time. Can I get your up-to-date assessment of each re: growth prospects and balance sheet stability? Would you consider any of them to be a buy and if so, in what order and is the current valuation reasonable?

Thank you, Doris
Read Answer Asked by Doris on October 12, 2022
Q: What's up with Well Health? Great results, analyst consensus of $9 - but stock stinks at $3.

Is Li Ka Shing still a shareholder? The last Cantech article seems unclear by saying "lead by..."; like "lead in spirit, but not dollars"? WELL is a sponsor of Cantech and Wadell owns shares personally, so the language and format of that article seem questionable. I kinda get the impression Li has liquidated his position but the company is tiptoeing around disclosing that. A couple sources say Li has "exited" but you may have clearer info from company IR.

I know Hamed Shabazi (ceo of WELL) is close friends with Sharzad Rafati, (ceo of BBTV) and that company has been an utter disaster. Hamed also sits on the board. Do you see any contagion spilling over? Similar problems, tricks or worse?

Something doesn't add up with the share performance of WELL based on their results, supposed high profile backers and analyst target consensus. Can they handle their debt? Have they overextended? Was that short report correct in their analysis of the CRH takeover? I mean that was a trash article; poorly researched and appears to be written by a confused teenager.

I like Hamed and followed him all the way back from the TIO days. I want to be sure that I am not picking up a scent similar to the fraudulent Canadian roll-up "darling" Patient Home Monitoring - I still have nightmares from that burn. The analysts all loved that one too. Well, thanks for your insight!
Read Answer Asked by Aidan on October 05, 2022
Q: Hi Peter and 5i team,
Can you please explain what happened to Abbvie on Friday? It seemed like an Analyst/Investment Company came out with a statement and then retracted it later on it the day. Thank you for the explanation.
Do you still think ABBV is positive going forward?
Thank you.
Read Answer Asked by Dennis on October 03, 2022
Q: Hello 5i Team,

Could you please provide your top 5 US healthcare stock picks for growth (with above-average risk) over the next 5 years, and include a brief comment why.

Could you also suggest 3 "safer" options.

Feel free to subtract as many credits as warranted.

Many thanks!
Read Answer Asked by Keith on September 22, 2022
Q: Retired, dividend-income investor. I own LIFE as my proxy for healthcare, with a current 6% weighting of my equities. I have money set aside to top it up a bit, but I wanted to check on two things first.

#1 = regarding where we are at in the overall market cycle is now a reasonable time to add to the health care sector? I have read that HC should be "ok" during a downturn. Would you agree?

#2 = is there any seasonality to healthcare? It doesn't appear to my eyes, but wanted to ask.

Thanks for your help...Steve
Read Answer Asked by Stephen on September 14, 2022
Q: In your comments on Biosyent Oct /21 , you indicated that , while very small , the company had impressive financials . Could I have your up-dated assessment post recent earnings and in particular in light of its announcement of an inaugural dividend by the end of this year.
Read Answer Asked by William on September 13, 2022
Q: Hi Team,
The stock performance of Well is a bit perplexing to me as of late. I understand that growth stocks in general have gotten slaughtered the last year. But this is a Health company (which I thought in general are supposed to fair well in "recession" type environments). The company so far has proven to be growing at a very high rate. Last numbers beat estimates if I remember correctly, and guidance upgraded. It had received some Price Target upgrades from analysts after the last release. Yet the share price continues to drift lower. Canada in general seems to have a healthcare "shortage" right now if you believe what the media tells us. You would think a company with "telehealth", which I think will have great future growth and help ease contstraints on hospitals somewhat would be catching the eye of long term investors here. As well, the CEO has a proven track record as building up a company and selling it. Am I missing something, or could this set up be one of the most compelling on the tsx today for long term buyers at this level? Also, is Well still a relatively "unknown" company to the investment world in canada? It seems that getting in early with unknown companies that end up sucessful can sometime generate outsized returns over the long haul. As is the notorious (10 baggers) everyone can dream of finding once in a lifetime. This all being said, should I be buying today for the buy and hold strategy? Your comments are appreciated. Thanks.
Read Answer Asked by Shane on September 09, 2022
Looking for more? Sign up for a FREE 14 day trial! No credit card required

We invite you to sign up for a 14 day free trial of 5i Research!
Experience all the benefits and tools we have to offer; stock research, model portfolios, Q&A with our experts, and so much more. Join a community of like-minded investors today!